Long-term Realism and Cost-effectiveness: Primary Prevention in Combatting Cancer and Associated Inequalities Worldwide
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The global figure of 14 million new cancer cases in 2012 is projected to rise to almost 22 million by 2030, with the burden in low- and middle-income countries (LMICs) shifting from 59% to 65% of all cancer cases worldwide over this time. While the overheads of cancer care are set to rapidly increase in all countries worldwide irrespective of income, the limited resources to treat and manage the growing number of cancer patients in LMICs threaten national economic development. Current data collated in the recent second edition of The Cancer Atlas by the American Cancer Society and International Agency for Research on Cancer show that a substantial proportion of cancers are preventable and that prevention is cost-effective. Therefore, cancer control strategies within countries must prioritize primary and secondary prevention, alongside cancer management and palliative care and integrate these measures into existing health care plans. There are many examples of the effectiveness of prevention in terms of declining cancer rates and major risk factors, including an 80% decrease in liver cancer incidence rates among children and young adults following universal infant hepatitis B vaccination in Taiwan and a 46% reduction in smoking prevalence in Brazil after the implementation of a more aggressive tobacco control program beginning in 1989. Prevention can bring rich dividends in net savings but actions must be promoted and implemented. The successful approaches to combatting certain infectious diseases provide a model for implementing cancer prevention, particularly in LMICs, via the utilization of existing infrastructures for multiple purposes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stuckler, D., McKee, M., Ebrahim, S., & Basu, S. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001235 · Cited by 666 · cited 1×
“diet, and obesity; these are often exacerbated by factors linked to the built environment (encouraging sedentary lifestyles) and national policy, including the extent to which multinational tobacco companies are able to target an economically developing country to expand market share and maximize profit (3,4).”
BackgroundAvoidable global cancer deaths and total deaths from smoking
Jha, P. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2703 · Cited by 522
Improvement of pathology in sub-Saharan Africa
Adesina, A., Chumba, D., Nelson, A. M., Orem, J., Roberts, D. J., Wabinga, H., Wilson, M., & Rebbeck, T. R. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70598-3 · Cited by 252
Bray, F., & Soerjomataram, I. (2015) · Disease Control Priorities, Third Edition (Volume 3): Cancer · doi:10.1596/978-1-4648-0349-9_ch2 · Cited by 209
Self-citationHealth and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries
Goldie, S. J., O'Shea, M., Campos, N. G., Diaz, M., Sweet, S., & Kim, S.-Y. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.04.053 · Cited by 197 · cited 1×
“Equally, there would be enormous dividends in LMICs following complete coverage of HPV vaccination: The cost to avert one disability-adjusted life-year is less than gross domestic product per capita, which makes it a very cost-effective intervention by World Health Organization standards (costs at the price negotiated…”
Background
Cited by
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Self-citationGlobal patterns and trends in colorectal cancer incidence and mortality
Arnold, M., Sierra, M. S., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2017) · Gut · doi:10.1136/gutjnl-2015-310912 · Cited by 5,228
Self-citationPlanning for tomorrow: global cancer incidence and the role of prevention 2020–2070
Soerjomataram, I., & Bray, F. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00514-z · Cited by 1,012
Self-citationMedical imaging and nuclear medicine: a Lancet Oncology Commission
Hricak, H., Abdel-Wahab, M., Atun, R., Lette, M. M., Paez, D., Brink, J. A., Donoso-Bach, L., Frija, G., Hierath, M., Holmberg, O., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30751-8 · Cited by 368
Hu, Z., & Ma, D. (2018) · Cancer Medicine · doi:10.1002/cam4.1501 · Cited by 338
Metadata
- Authors
- Bray, F., Jemal, A., Torre, L. A., Forman, D., & Vineis, P.
- Venue
- Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-09-30
- Volume
- 107
- Issue
- 12
- Pages
- djv273
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2181458187
- Cited by
- 119
- References
- 5
- FWCI
- 4.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long-term Realism and Cost-effectiveness: Primary Prevention in Combatting Cancer and Associated Inequalities Worldwide. https://app.cochat.ai/papers/10.1093/jnci/djv273
- The paper
- Bray, F., Jemal, A., Torre, L. A., Forman, D., & Vineis, P. (2015). Long-term Realism and Cost-effectiveness: Primary Prevention in Combatting Cancer and Associated Inequalities Worldwide. Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djv273
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.